evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract
19778,GENE_BACKGROUND,,"DOT1L encodes for DOT1-like histone H3K79 methyltransferase, methylating the histone 3 lysine 79 residue (PMID:12123582). H3K79 methylation is associated with DNA damage response to double stranded breaks (PMID:15525939). This modification has also been implicated in diverse cellular and developmental processes including cell division, embryonic development, meiosis, and hematopoiesis (PMID:21724828, 24526115). H3K79 methylation modifies chromatin structure and can promote active transcription (PMID:18285465). In leukemias, this modification promotes active transcription by preventing the binding of the inhibitory Sirtuin1 (SIRT1) complex (PMID:25822366). In Mixed lineage leukemia (MLL) translocation leukemias, DOT1L was shown to be important for the transformation activity of the MLL fusion protein, and inhibitors of DOT1L have been employed in the treatment of this subset of leukemias (PMID:18977325, 15851025, 21741596). In breast cancer, DOT1L has been shown to cooperate with a c-Myc-p300 complex to promote epithelial to mesechymal transition and clinically be associated with more aggressive disease (PMID:26199140). Mutations in DOT1L have been identified in large-scale sequencing efforts of solid tumors including colon, small cell lung cancer, and squamous head and neck cancer (PMID:22810696, 26168399, 25056374).",,2017-01-09,,84444,DOT1L,DOT1 like histone lysine methyltransferase,False,ENST00000398665,NM_032482.2,KMT4,DOT1,False,26199140,DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression.,Nature communications,2018-07-22T20:15:00,6,,7821,Cho MH et al,doi: 10.1038/ncomms8821,,0001-07-22,,12123582,Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain.,Current biology : CB,2018-06-25T20:02:00,12,12,1052-8,Feng Q et al,,,0001-06-25,,18285465,DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.,Molecular and cellular biology,2018-04-01T20:08:00,28,8,2825-39,Steger DJ et al,doi: 10.1128/MCB.02076-07,,0001-04-01,,24526115,The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle.,"Cell cycle (Georgetown, Tex.)",2014,13,5,726-38,Kim W et al,doi: 10.4161/cc.28104,,"Kim W et al. Cell cycle (Georgetown, Tex.). 2014;13(5)726-38.",,22810696,Comprehensive molecular characterization of human colon and rectal cancer.,Nature,2018-07-18T20:12:00,487,7407,330-7,Cancer Genome Atlas Network.,doi: 10.1038/nature11252,,0001-07-18,,25822366,DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.,Nature medicine,2018-04-01T20:15:00,21,4,335-43,Chen CW et al,doi: 10.1038/nm.3832,,0001-04-01,,18977325,H3K79 methylation profiles define murine and human MLL-AF4 leukemias.,Cancer cell,2018-11-04T20:08:00,14,5,355-68,Krivtsov AV et al,doi: 10.1016/j.ccr.2008.10.001,,0001-11-04,,26168399,Comprehensive genomic profiles of small cell lung cancer.,Nature,2018-08-06T20:15:00,524,7563,47-53,George J et al,doi: 10.1038/nature14664,,0001-08-06,,21724828,The diverse functions of Dot1 and H3K79 methylation.,Genes &amp; development,2018-07-01T20:11:00,25,13,1345-58,Nguyen AT et al,doi: 10.1101/gad.2057811,,0001-07-01,,25056374,Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-02-01T20:15:00,21,3,632-41,Seiwert TY et al,doi: 10.1158/1078-0432.CCR-13-3310,,0001-02-01,,21741596,Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.,Cancer cell,2018-07-12T20:11:00,20,True,53-65,Daigle SR et al,doi: 10.1016/j.ccr.2011.06.009,,0001-07-12,,15851025,hDOT1L links histone methylation to leukemogenesis.,Cell,2018-04-22T20:05:00,121,2,167-78,Okada Y et al,,,0001-04-22,,15525939,Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks.,Nature,2017-11-18T20:04:00,432,7015,406-11,Huyen Y et al,,,0001-11-18,
19777,GENE_SUMMARY,,"DOT1L encodes for a histone 3 lysine 79 methyltransferase. DOT1L inhibitors have been developed to treat MLL translocation associated acute myeloid leukemias, while mutations have been identified in solid tumors including colon and lung cancer.",,2017-01-09,,84444,DOT1L,DOT1 like histone lysine methyltransferase,False,ENST00000398665,NM_032482.2,KMT4,DOT1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
